Smiths Group PLC to Discuss Agreement for the Sale of Smiths Medical to TA Associates Management LP Call Transcript
Good day, and thank you for standing by. Welcome to the Smiths Group plc call. (Operator Instructions) I would now like to hand the conference over to your speaker today, Paul Keel. Please go ahead.
Good morning, everyone, and thank you for joining us today. For those of you, who I've not yet met, my name is Paul Keel, and I had the honor of joining this great company as CEO in May. I am joined today by our CFO, John Shipsey. We are pleased to announce that we have entered into a definitive agreement to sell Smiths Medical for a price of USD 2.3 billion plus an additional $0.2 billion contingent on future performance of Smiths Medical. This delivers on the commitment we made to separate this business and focuses our attention, resources and capital on the many exciting opportunities available to us in Smiths' attractive industrial technology core. Let me walk you through the details of today's announcement, beginning on Slide 3.
We took the decision to separate Medical in order to simplify
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |